EMEA-000917-PIP02-11

Key facts

Invented name
Lumigan
Active substance
bimatoprost
Therapeutic area
Dermatology
Decision number
P/0089/2012
PIP number
EMEA-000917-PIP02-11
Pharmaceutical form(s)
Cutaneous solution
Condition(s) / indication(s)
Treatment of androgenic alopecia
Route(s) of administration
Cutaneous use
Contact for public enquiries
Allergan Pharmaceuticals International Limited

E-mail: ml-eu_reg_affairs@allergan.com
Tel. +44 (0)1628 4944444

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

Related content

How useful was this page?

Add your rating